NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.05
(-11.54%)
AUD 0.05
(-11.54%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.05 Million AUD | 66.42% |
| 2023 | -6.12 Million AUD | 41.69% |
| 2022 | -10.5 Million AUD | -148.69% |
| 2021 | -4.22 Million AUD | -43.59% |
| 2020 | -2.94 Million AUD | -78.1% |
| 2019 | -1.65 Million AUD | -71.91% |
| 2018 | -960.71 Thousand AUD | -221.61% |
| 2017 | -298.72 Thousand AUD | -36.36% |
| 2016 | -219.07 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.31 Million AUD | 0.0% |
| 2024 Q4 | -745.15 Thousand AUD | 0.0% |
| 2024 FY | -2.05 Million AUD | 66.42% |
| 2023 Q4 | -1.84 Million AUD | 0.0% |
| 2023 FY | -6.12 Million AUD | 41.69% |
| 2023 Q2 | -4.27 Million AUD | 0.0% |
| 2022 Q2 | -5.76 Million AUD | 0.0% |
| 2022 FY | -10.5 Million AUD | -148.69% |
| 2022 Q4 | -4.73 Million AUD | 0.0% |
| 2021 FY | -4.22 Million AUD | -43.59% |
| 2021 Q2 | -1.66 Million AUD | 0.0% |
| 2021 Q4 | -2.55 Million AUD | 0.0% |
| 2020 Q4 | -1.02 Million AUD | 0.0% |
| 2020 FY | -2.94 Million AUD | -78.1% |
| 2020 Q2 | -1.91 Million AUD | 0.0% |
| 2019 Q4 | -864.95 Thousand AUD | 0.0% |
| 2019 Q2 | -752.74 Thousand AUD | 0.0% |
| 2019 FY | -1.65 Million AUD | -71.91% |
| 2018 Q2 | -324.9 Thousand AUD | 0.0% |
| 2018 FY | -960.71 Thousand AUD | -221.61% |
| 2018 Q4 | -606.93 Thousand AUD | 0.0% |
| 2017 FY | -298.72 Thousand AUD | -36.36% |
| 2017 Q2 | -152.79 Thousand AUD | -100.0% |
| 2017 Q4 | -107.9 Thousand AUD | 0.0% |
| 2017 Q1 | -76.39 Thousand AUD | 0.0% |
| 2016 FY | -219.07 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 60.914% |
| Acrux Limited | -9.83 Million AUD | 79.087% |
| Actinogen Medical Limited | -12.83 Million AUD | 83.982% |
| AnteoTech Limited | -11.72 Million AUD | 82.462% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 63.737% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 71.409% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -40.945% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 89.508% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 53.524% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 55.187% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 32.846% |
| Biome Australia Limited | -1.91 Million AUD | -7.491% |
| Biotron Limited | -5.15 Million AUD | 60.076% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 86.01% |
| BTC Health Limited | 1.05 Million AUD | 294.882% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 83.293% |
| CSL Limited | 5.64 Billion AUD | 100.036% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 95.41% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 104.184% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 76.651% |
| Dimerix Limited | -25.05 Million AUD | 91.793% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 121.166% |
| Hexima Limited | -1 Million AUD | -103.872% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 28.437% |
| Immuron Limited | -5.8 Million AUD | 64.549% |
| Immutep Limited | -44.93 Million AUD | 95.423% |
| Imugene Limited | -140.93 Million AUD | 98.541% |
| Invex Therapeutics Ltd | -2.13 Million AUD | 3.612% |
| Memphasys Limited | -2.7 Million AUD | 23.944% |
| Nanollose Limited | -1.24 Million AUD | -64.548% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 100.91% |
| Noxopharm Limited | -7.53 Million AUD | 72.707% |
| Nyrada Inc. | -4.56 Million AUD | 54.903% |
| Orthocell Limited | -11.68 Million AUD | 82.394% |
| PharmAust Limited | -6.65 Million AUD | 69.114% |
| Patrys Limited | -3.53 Million AUD | 41.891% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 96.842% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 71.561% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 71.383% |
| PYC Therapeutics Limited | -38.85 Million AUD | 94.707% |
| Race Oncology Limited | -13.38 Million AUD | 84.63% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 95.644% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 90.674% |
| Starpharma Holdings Limited | -15.15 Million AUD | 86.433% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | 57.822% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 65.367% |